Bharat Biotech`s Covaxin gets DGCI nod to conduct clinical trials on children above 2 years
The national drug regulator said that it has accepted the recommendation of the SEC “after careful examination” and accorded permission to Covaxin manufacturer Bharat Biotech.
from Zee News :India National https://ift.tt/3fiuTfR
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words.
0 Comments